Vinci Compass Q2 2026 slides: FRE jumps 36% on acquisitions, scale
Vinci Compass Q2 2026 slides: FRE jumps 36% on acquisitions, scale
Year: 2026
NeuroPace Q2 2026 slides: 21% RNS growth, $55B+ market opportunity
NeuroPace Q2 2026 slides: 21% RNS growth, $55B+ market opportunity
Grupo Supervielle Q2 2026 slides: return to profit, 20% NIM
Grupo Supervielle Q2 2026 slides: return to profit, 20% NIM
Global Investors Favor Taiwan Over Korea Stocks After AI Selloff
Taiwanese stocks are gaining favor over South Korea’s on steadier earnings prospects, as the two AI-bellwether markets look to recover from July’s rout.
As Berkshire goes on a $20B buying spree, these AI-picked stocks are up +204%
As Berkshire goes on a $20B buying spree, these AI-picked stocks are up +204%
Mirum Pharmaceuticals CEO Christopher Peetz sells $1.98 million in shares
Mirum Pharmaceuticals CEO Christopher Peetz sells $1.98 million in shares
Kemper Corp director Jason Gorevic buys $129,550 in stock
Kemper Corp director Jason Gorevic buys $129,550 in stock
Honest Co. director Andrea Turner sells $338,072 in stock
Honest Co. director Andrea Turner sells $338,072 in stock
Net Power director 8 Rivers Capital sells $234,144 in class A stock
Net Power director 8 Rivers Capital sells $234,144 in class A stock
Cabot CEO Sean Keohane sells $7.9m in stock
Cabot CEO Sean Keohane sells $7.9m in stock